AVIR Stock-Based Compensation
Atea Pharmaceuticals Inc · Stock-Based Compensation
AVIR Stock-Based Compensation
Latest reported$16.21Mperiod ending
AVIR TTM Stock-Based Comp ($624.00K → $16.21M)
TTM stock-based compensation
High-resolution chart · PNG
AVIR stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 16,212,000 | |
| 17,498,000 | |
| 20,720,000 | |
| 30,432,000 | |
| 38,079,000 | |
| 46,132,000 | |
| 51,767,000 | |
| 49,627,000 | |
| 49,846,000 | |
| 49,479,000 | |
| 49,428,000 | |
| 48,916,000 | |
| 48,037,000 | |
| 47,592,000 | |
| 46,718,000 | |
| 46,424,000 | |
| 45,910,000 | |
| 44,009,000 | |
| 39,621,000 | |
| 31,091,000 | |
| 24,339,000 | |
| 14,541,000 | |
| 7,457,000 | |
| 4,810,000 | |
| 729,000 | |
| 667,000 | |
| 624,000 |